Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Cell Reports. Medicine|May 17, 2023
Learning while treating: Gain-of-function STAT6 variants in severe allergic diseaseTukisa D Smith, Taylor A Doherty
Current Opinion in Allergy and Clinical Immunology|December 11, 2020
Cellular interactions in aspirin-exacerbated respiratory diseaseJana H Badrani, Taylor A Doherty
JAK-STAT|January 14, 2014
STAT6 and lung inflammationHannah H Walford, Taylor A Doherty
Nature Reviews. Immunology|February 25, 2006
CATERPILLERs, pyrin and hereditary immunological disordersJenny P-Y Ting, Daniel L Kastner, Hal M Hoffman
The Journal of Allergy and Clinical Immunology|November 14, 2009
Familial atypical cold urticaria: description of a new hereditary diseaseChhavi Gandhi, Chris Healy, Alan A Wanderer, et al.
Current Medical Research and Opinion|August 1, 2008
Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activityHal M Hoffman, Frederick Wolfe, Pavel Belomestnov, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammationSudipta Das, Marina Miller, Andrew K Beppu, et al.
Immunotargets and Therapy|March 20, 2026
Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune DisordersSvetlana Blitshteyn, Taylor A Doherty, Lawrence Steinman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 21, 2023
Military burn pit exposure and airway disease: Implications for our Veteran populationXinyu Wang, Taylor A Doherty, Christine James
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2007
Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonistBrian D Thornton, Hal M Hoffman, Adarsh Bhat, et al.
Pageof 22